A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Update Il y a 4 ans
Reference: NCT01751152

Woman and Man

Extract

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to assess clinical efficacy and safety of NNC0114-0006 in subjects with active Crohn's disease.


Inclusion criteria

  • Inflammation ,Crohn’s Disease


Links